518 related articles for article (PubMed ID: 9172836)
1. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission.
Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG
Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
Mettenleiter TC; Klupp BG; Weiland F; Visser N
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
[TBL] [Abstract][Full Text] [Related]
4. Pseudorabies (Aujeszky's disease) virus: state of the art. August 1993.
Mettenleiter TC
Acta Vet Hung; 1994; 42(2-3):153-77. PubMed ID: 7810409
[TBL] [Abstract][Full Text] [Related]
5. Assessment of replication and virulence of attenuated pseudorabies virus in swine.
Newby TJ; Carter DP; Yoon KJ; Jackwood MW; Hawkins PA
J Vet Sci; 2002 Jun; 3(2):61-6. PubMed ID: 12441673
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity.
Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J
Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253
[TBL] [Abstract][Full Text] [Related]
8. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
9. Aujeszky's disease virus strains with peculiar features.
Motovski AD
Acta Vet Hung; 1994; 42(2-3):213-6. PubMed ID: 7810415
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein I of pseudorabies virus (Aujeszky's disease virus) determines virulence and facilitates penetration of the virus into the central nervous system of pigs.
Jacobs L; Mulder WA; Priem J; Pol JM; Kimman TG
Acta Vet Hung; 1994; 42(2-3):289-300. PubMed ID: 7810422
[TBL] [Abstract][Full Text] [Related]
11. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
Kelling CL; Staudinger WL; Rhodes MB
Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity.
de Wind N; Berns A; Gielkens A; Kimman T
J Gen Virol; 1993 Mar; 74 ( Pt 3)():351-9. PubMed ID: 8383170
[TBL] [Abstract][Full Text] [Related]
13. Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs.
Bouma A; De Jong MC; Kimman TG
Am J Vet Res; 1996 Jan; 57(1):43-7. PubMed ID: 8720236
[TBL] [Abstract][Full Text] [Related]
14. Replication and pathogenicity after intranasal and intracranial inoculation of swine with a recombinant pseudorabies virus containing a deletion at the UL/IR junction.
Dean HJ; Miller JM; Ackermann MR; Gao XY; Anderson LL; Jacobson CD; Cheung AK
Virology; 1996 Sep; 223(1):19-28. PubMed ID: 8806536
[TBL] [Abstract][Full Text] [Related]
15. Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host.
Dijkstra JM; Gerdts V; Klupp BG; Mettenleiter TC
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2147-51. PubMed ID: 9292000
[TBL] [Abstract][Full Text] [Related]
16. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
Kit S; Kit M; McConnell S; Lawhorn B
Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
[TBL] [Abstract][Full Text] [Related]
17. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins.
Dory D; Torché AM; Béven V; Blanchard P; Loizel C; Cariolet R; Jestin A
Vaccine; 2005 May; 23(26):3483-91. PubMed ID: 15837372
[TBL] [Abstract][Full Text] [Related]
18. A live gI/gE-deleted pseudorabies virus (PRV) protects weaned piglets against lethal variant PRV challenge.
Yin Y; Xu Z; Liu X; Li P; Yang F; Zhao J; Fan Y; Sun X; Zhu L
Virus Genes; 2017 Aug; 53(4):565-572. PubMed ID: 28417300
[TBL] [Abstract][Full Text] [Related]
19. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
[TBL] [Abstract][Full Text] [Related]
20. The influence of recombination on the genetic stability of pseudorabies vaccine virus.
Visser N
Dev Biol Stand; 1995; 84():97-104. PubMed ID: 7796973
[No Abstract] [Full Text] [Related]
[Next] [New Search]
